SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending as investors monitor its potential selection for S&P 500 inclusion, with speculation intensifying after recent market rallies and institutional buying. While many traders remain bullish on its role in AI infrastructure, others express caution, highlighting volatility and skepticism regarding the timing of the anticipated announcement.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a mix of speculative trading and investor anticipation ahead of expected manufacturing updates and industry conferences scheduled for September. While bullish traders emphasize the company's production scale-up and potential for upcoming commercial announcements, others remain skeptical, pointing to the lack of material revenue and historical volatility.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla shares declined as the much-anticipated Cybercab event drew criticism from analysts and investors, who flagged limited disclosure, the lack of a livestream, and unresolved regulatory hurdles. Adding pressure, the NHTSA initiated an audit into the vehicle's certification, fueling trader uncertainty and contributing to a shift toward a more cautious sentiment.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 shares are trending amid a combination of anticipation for upcoming quarterly earnings and ongoing speculation regarding potential developments in Texas energy approvals. Community sentiment remains divided, with some investors focusing on long-term data center expansion prospects while others express frustration over technical performance and management's recent execution.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix shares are under pressure as investors weigh the impact of recent subscription price hikes in the United Kingdom, sparking debate over whether the move will boost revenue or lead to customer churn. While some traders view the decline as a buying opportunity, others remain cautious about potential subscriber losses and the stock's recent volatility.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing significant downward pressure following disappointing quarterly results, a reduced full-year outlook, and ongoing concerns about declining North American demand and brand heat. While many traders remain bearish due to these fundamentals and analyst downgrades, some are viewing the sub-$100 price level as an opportunistic "fat pitch" for a long-term turnaround, heavily influenced by investor Michael Burry's stated interest in buying the dip.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Investors are largely divided between optimism over long-term prospects, such as a recently signed multi-billion dollar contract with TensorWave, and frustration regarding the company's lack of immediate revenue and delays in announcing a Tier 1 financing guarantor. The stock's price decline has sparked intense debate among the community, with some traders viewing it as a prime accumulation opportunity for an eventual breakout, while others raise concerns about management execution and potential dilution.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as traders speculate on a potential short squeeze, citing high short interest and institutional activity while expressing bullish sentiment regarding its transition into an AI infrastructure and data center provider. The conversation is characterized by a strong debate between participants anticipating a major rally toward higher price targets and others dismissing the move as a temporary short-covering rally or 'bull trap.'

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending as traders debate its potential for upcoming S&P 500 inclusion and react to significant volatility following its recent earnings report. While some participants view current price levels as a buying opportunity based on strong growth fundamentals and analyst upgrades, others remain skeptical, citing risks related to insider selling and speculative positioning.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as investors react to the company's strong oncology revenue growth and recent positive Phase 3 trial results for its COPD drug, tozorakimab. Community discussion is focused on the stock's long-term growth potential and strategic pipeline updates, while the stock continues to be a central topic for investors monitoring the broader pharmaceutical sector's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday

Nasdaq: NYAX rose 13.9% on Tuesday after announcing acquisition of IPS Group Inc. for $350 million. Other big gainers include CAPR, RZLV, CRML, and MAIR.read more...

MRNA Advances Cancer Pipeline With New Immunotherapy Study

Moderna doses the first U.S. participant in a phase I study of mRNA-4200, advancing its off-the-shelf cancer therapy pipeline beyond vaccines.

Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates

Immatics (IMTX) delivered earnings and revenue surprises of -19.05% and -38.95%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Acadia's first-quarter earnings and revenues miss estimates despite 10% sales growth, driven by Nuplazid and Daybue demand.

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

MDGL stock up on better-than-expected first-quarter results on account of robust Rezdiffra sales, driven by strong MASH demand and rising patient adoption.

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

Recursion Pharmaceuticals reports a narrower-than-expected Q1 loss, but revenues fall sharply as Roche collaboration income declines year over year.

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) delivered earnings and revenue surprises of -15.99% and -45.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy

Immatics (IMTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Novo Nordisk stock jumps as Q1 earnings and revenues beat estimates, fueled by strong Wegovy and Ozempic demand and a raised 2026 outlook.

Immatics (IMTX) to Release Quarterly Earnings on Tuesday

Immatics (NASDAQ:IMTX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-immatics-stock...

• Reported GAAP EPS of -$0.46 up 20.69% YoY
• Reported revenue of $9.14M up 93.03% YoY

Immatics N.V. faces increased research and development costs and net losses, while the SUPRAME trial is experiencing slower-than-modeled progression events, requiring a shift in the primary clinical endpoint analysis strategy.

Immatics N.V. demonstrated durable clinical activity for its PRAME franchise in melanoma and gynecologic cancers, while achieving a key milestone in its mRNA collaboration with Moderna to expand therapeutic reach.

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.

Immatics N.V

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.53	--	--	N/A
Q2 '26	-$0.48	-$0.53	-10.96%	MISSED
Q1 '26	-$0.46	-$0.50	-7.43%	MISSED
Q4 '25	-$0.49	-$0.33	32.19%	BEAT
Q3 '25	-$0.43	-$0.49	-12.92%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

IMTX Earnings

Latest Earnings Results: Q2 '26

Historical Earnings